Niccolo Bolli

Milan, 20122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 122 publications

In search of dependencies in myeloma, consider IRF2 too.

In search of dependencies in myeloma, consider IRF2 too.

Journal: Blood

Published: June 25, 2026

How Laboratory Innovations Are Shaping the Future of Multiple Myeloma Care.

How Laboratory Innovations Are Shaping the Future of Multiple Myeloma Care.

Journal: Cancers

Published: March 17, 2026

Pathogenic and Clinical Implications of the 2-Way Interplay Between Clonal Hematopoiesis of Indeterminate Potential and Multiple Myeloma.

Pathogenic and Clinical Implications of the 2-Way Interplay Between Clonal Hematopoiesis of Indeterminate Potential and Multiple Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: February 17, 2026

Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application.

Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life Application.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 03, 2025

Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple Myeloma.

Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple Myeloma.

Journal: Journal of cellular and molecular medicine

Published: October 28, 2025

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 08, 2025

Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.

Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.

Journal: Cancer medicine

Published: October 07, 2025

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape.

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape.

Journal: ESMO open

Published: July 11, 2025

Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.

Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 25, 2025

Granuloma annulare-like pseudohistiocytosis: a specific manifestation of ETV6::SYK-rearranged myeloid neoplasm with eosinophilia.

Granuloma annulare-like pseudohistiocytosis: a specific manifestation of ETV6::SYK-rearranged myeloid neoplasm with eosinophilia.

Journal: Haematologica

Published: June 24, 2025

European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma.

European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma.

Journal: HemaSphere

Published: June 16, 2025

Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).

Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).

Journal: Research square

Published: June 12, 2025

Showing 1-12 of 122

Last Updated: 09/26/2026